Literature DB >> 28028565

Severe cerebral hypovolemia on perfusion CT and lower body weight are associated with parenchymal haemorrhage after thrombolysis.

S Tsetsou1, M Amiguet2, A Eskandari3, R Meuli4, P Maeder4, B Jiang5, M Wintermark5, P Michel3.   

Abstract

INTRODUCTION: Haemorrhagic transformation of acute ischemic stroke (AIS) and particularly parenchymal haemorrhage (PH) remains a feared complication of intravenous thrombolysis (IVT). We aimed to identify clinical and perfusion CT (PCT) variables which are independently associated with PHs.
METHODS: In this observational cohort study, based on the Acute Stroke Registry Analysis of Lausanne (ASTRAL) from 2003 to December 2013, we selected patients with AIS involving the middle cerebral artery (MCA) territory who were thrombolysed within 4.5 h of symptoms' onset and who had a good quality baseline PCT at the beginning of IVT. In addition to demographic, clinical, laboratory and non-contrast CT data, volumes of salvageable tissue and ischemic core on PCT, as well as absolute CBF and CBV values within the ischemic regions were compared in patients with and without PH in multivariate analysis.
RESULTS: Of the 190 included patients, 24 (12.6%) presented a PH (11 had PH1 and 13 had PH2). In multivariate analysis of the clinical and radiological variables, the lowest CBV in the core and lower body weight was both significantly associated with PH (p = 0.009 and p = 0.024, respectively).
CONCLUSION: In thrombolysed MCA strokes, maximal hypoperfusion severity depicted by lowest CBV values in the core region and lower body weight are independently correlated with PH. This information, if confirmed in other case series, may add to the stratification of revascularisation decisions in patients with a perceived high PH risk.

Entities:  

Keywords:  Parenchymal haemorrhage; Perfusion CT; Stroke

Mesh:

Substances:

Year:  2016        PMID: 28028565     DOI: 10.1007/s00234-016-1775-x

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  51 in total

1.  Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.

Authors:  Götz Thomalla; Jan Sobesky; Martin Köhrmann; Jochen B Fiebach; Jens Fiehler; Olivier Zaro Weber; Anna Kruetzelmann; Thomas Kucinski; Michael Rosenkranz; Joachim Röther; Peter D Schellinger
Journal:  Stroke       Date:  2007-01-04       Impact factor: 7.914

2.  Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction.

Authors:  M FISHER; R D ADAMS
Journal:  J Neuropathol Exp Neurol       Date:  1951-01       Impact factor: 3.685

3.  The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging.

Authors:  Patrik Michel; Céline Odier; Matthieu Rutgers; Marc Reichhart; Philippe Maeder; Reto Meuli; Max Wintermark; Ali Maghraoui; Mohamed Faouzi; Alexandre Croquelois; George Ntaios
Journal:  Stroke       Date:  2010-10-07       Impact factor: 7.914

4.  Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke.

Authors:  J Hom; J W Dankbaar; B P Soares; T Schneider; S-C Cheng; J Bredno; B C Lau; W Smith; W P Dillon; M Wintermark
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-14       Impact factor: 3.825

5.  Acute stroke imaging research roadmap.

Authors:  Max Wintermark; Gregory W Albers; Andrei V Alexandrov; Jeffry R Alger; Roland Bammer; Jean-Claude Baron; Stephen Davis; Bart M Demaerschalk; Colin P Derdeyn; Geoffrey A Donnan; James D Eastwood; Jochen B Fiebach; Marc Fisher; Karen L Furie; Gregory V Goldmakher; Werner Hacke; Chelsea S Kidwell; Stephan P Kloska; Martin Köhrmann; Walter Koroshetz; Ting-Yim Lee; Kennedy R Lees; Michael H Lev; David S Liebeskind; Leif Ostergaard; William J Powers; James Provenzale; Peter Schellinger; Robert Silbergleit; Alma Gregory Sorensen; Joanna Wardlaw; Ona Wu; Steven Warach
Journal:  Stroke       Date:  2008-04-10       Impact factor: 7.914

6.  Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.

Authors:  Richard Leigh; Shyian S Jen; Argye E Hillis; John W Krakauer; Peter B Barker
Journal:  Stroke       Date:  2014-05-15       Impact factor: 7.914

7.  Improving prediction of recanalization in acute large-vessel occlusive stroke.

Authors:  P Vanacker; D Lambrou; A Eskandari; P Maeder; R Meuli; G Ntaios; P Michel
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke.

Authors:  Zhong-Song Shi; Yince Loh; David S Liebeskind; Jeffrey L Saver; Nestor R Gonzalez; Satoshi Tateshima; Reza Jahan; Lei Feng; Paul M Vespa; Sidney Starkman; Noriko Salamon; J Pablo Villablance; Latisha K Ali; Bruce Ovbiagele; Doojin Kim; Fernando Viñuela; Gary R Duckwiler
Journal:  Stroke       Date:  2012-05-10       Impact factor: 7.914

10.  Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke.

Authors:  V Palumbo; J M Boulanger; M D Hill; D Inzitari; A M Buchan
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

View more
  1 in total

1.  Perfusion CT for prediction of hemorrhagic transformation in acute ischemic stroke: a systematic review and meta-analysis.

Authors:  Chong Hyun Suh; Seung Chai Jung; Se Jin Cho; Donghyun Kim; Jung Bin Lee; Dong-Cheol Woo; Woo Yong Oh; Jong Gu Lee; Kyung Won Kim
Journal:  Eur Radiol       Date:  2019-01-07       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.